Dr Zhou Lihan is bolstering the future of preventive healthcare
On the eve of Mirxes’s listing application with The Stock Exchange of Hong Kong Limited, CBD sat down with the biotech’s far-sighted CEO and co-founder Dr Zhou Lihan to find out how cognitive diversity lends to his firm’s advancements in making the early detection of diseases accessible on a global scale.